Live Feed/OpenAI/Fact Record
OpenAI logo
OpenAI
feature 96% Confidence Gate September 10, 2026

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

César de la Fuente’s lab is utilizing OpenAI's Codex and ChatGPT models to automate the identification of antimicrobial peptides within biological datasets. This workflow integrates large language models into the computational pipeline for drug discovery.

Verified State Diff

Comparison Mode:
- Previous State
Antimicrobial discovery relied on traditional bioinformatics pipelines and manual sequence analysis without LLM-assisted code generation or natural language interpretation.
+ Verified New State
Researchers can now leverage Codex for automated code generation to process genomic sequences and ChatGPT for interpreting complex biological data to identify antimicrobial candidates.

Impact & Verification Analysis

WHO IS AFFECTED

Bioinformatics researchers, pharmaceutical developers, and computational biologists.

WHY IT MATTERS

It demonstrates the practical application of LLMs in high-stakes scientific research, specifically in accelerating the discovery of life-saving therapeutics through automated sequence analysis.

Full Fact Overview

The integration involves using Codex to generate code for processing genomic data and ChatGPT to assist in the analysis and interpretation of antimicrobial candidates. By applying these models to both living and extinct genomes, the lab accelerates the screening process for molecules capable of combating antibiotic-resistant pathogens, shifting the bottleneck from manual sequence analysis to model-assisted computational prediction.

Multi-Source Evidence Chain (1)

How a researcher uses Codex and ChatGPT to search for new antimicrobial moleculesOpenAI
TRACKED ENTITY
Explore all historical OpenAI changes
View OpenAI Hub ➔